Deciphera Pharmaceuticals Announces First Quarter 2023 Financial Results
– First Quarter 2023 Total Revenue of $33.4 Million; Net Product Revenue for QINLOCK® Increased 15% to $33.2 Million Compared to First Quarter 2022 – – Enrollment Complete in... | May 3, 2023